Immunoembolization in liver-predominant metastatic uveal melanoma: a single-center retrospective analysis

IntroductionApproximately 50% of patients with uveal melanoma develop metastatic disease, most commonly involving the liver, and prognosis remains poor. Immunoembolization (IE) is an established liver-directed therapy for patients with liver-dominant metastatic uveal melanoma (mUM), though comparati...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Renee Morecroft, Jordan Phillipps, Amrat Kumar, Jacob Strelnikov, George Nassief, Naganathan Mani, Jennifer Gould, Tanner Johanns, George Ansstas
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2026-04-01
Edice:	Frontiers in Oncology
Témata:	liver-predominant metastatic uveal melanoma liver-directed therapy immunoembolization melphalan hepatic delivery system FOCUS trial progression-free survival
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fonc.2026.1752725/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!